Aamaxan Transport Group, Inc. (AAXT) Stock
Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Aamaxan Transport Group, Inc.
Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy. The company was founded as Shanghai Medical Technology Co., Ltd. and changed its name to Aamaxan Transport Group, Inc. in April 2008. The company is based in Shanghai, China.
Aamaxan Transport Group, Inc. (AAXT) stock trades at $0.00 with a market capitalization of $1599. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Aamaxan Transport Group, Inc. generates a return on equity (ROE) of 54.17% — well above the market average, a sign of a high-quality business, return on capital employed of -42.63%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.amax-tech.com